Medicare is Finally Covering Weight-Loss Drugs: What You Need to Know
About one in eight adults now takes a GLP-1 drug to help lose weight. For years, though, Medicare users…
-
-
What to Expect from Eli Lilly’s Next Earnings Report?
Eli Lilly is currently leading the market in diabetes and weight-loss drugs. A huge chunk of the company’s money…
-
Could Weight-Loss Drugs Be Curing Our Alcohol Cravings?
It turns out that semaglutide, the active ingredient in popular GLP-1 drugs like Wegovy and Ozempic, does more than…
-
How GLP-1 Weight-Loss Drugs Are Forcing Restaurants to Rethink Their Menus
Weight-loss drugs like Ozempic and Wegovy aren’t just changing waistlines, they are changing how Americans eat out. According to…
-
Burger King Adjusts Its Menu Strategy as GLP-1 Drug Use Reshapes Fast Food Demand
Burger King’s leaders are getting ready for a big, long-term shift in how people eat and they think GLP-1…
-
GLP-1 Weight Loss Fuels Emerging Market for Post-Treatment Body Restoration
GLP-1 drugs have helped millions of people lose weight fast. But there’s a side effect nobody really talks about:…
-
Weight Loss Drugs for Cats? Scientists Are Testing It
Could the same drugs helping people lose weight soon help overweight cats too? Two biotech companies are trying to…
-
FDA Warns 30 Telehealth Companies Over Weight-Loss Drug Ads
The FDA has sent warning letters to 30 telehealth companies this week, saying their marketing for compounded weight-loss drugs…
-
Stopping GLP-1 Drugs May Raise Mental Health Risks in Type 2 Diabetes Patients
New research shows that people who stop taking GLP-1 receptor agonist drugs may face a higher risk of mental…
-
Diet Coke Resolves Stomach Blockage Linked to Ozempic Use in Massachusetts Patient
A 63-year-old woman in Massachusetts avoided surgery after doctors used something surprising to treat her: diet soda. The woman,…
